SEARCH

SEARCH BY CITATION

References

  • 1
    Kuwert E, Scheiermann N, Gesemann M, et al. Dose range study in healthy volunteers of a hepatitis B vaccine produced in yeast. Antiviral Res 1985; (Suppl 1):281288.
  • 2
    West DJ. Clinical experience with hepatitis B vaccines. Am J Infect Control 1989;17:17280.
  • 3
    Francis DP, Hadler SC, Thompson SE, et al. The prevention of hepatitis B with vaccine. Report of the Centers for Disease Control multicenter efficacy trial among homosexual men. Ann Intern Med 1982;97:362366.
  • 4
    Anonymous. Hepatitis B targets endorsed by the World Health Assembly. Perspectives 1992;3:12.
  • 5
    Lee C-Y. Control of hepatitis B by vaccination in a country in which it is endemic. Critical issues for control of hepatitis B. Proceedings of a Series of Symposia. Asia Pacific Congress Series No. 112; November 1989; Excerpta Medica, Asia Ltd, Hong Kong : 712.
  • 6
    Salleras L, Taberner JL, Barber E, et al. Programa de vacunación de la hepatitis B en adolescentes de Cataluna. Gastroenterol Hepatology 1994;17:349352.
  • 7
    Obligatorietà della vaccinazione contro l'epatite B. Legge 27 Maggio 1991; No. 165; Gazzetta Ufficiale delia Republica Italiana, Serie Generale No. 127; 1 June 1991.
  • 8
    World Health Organization. Expanded program on Immunization. Program Report 1993. (Incorporates the conclusions and recommendations of the Global Advisory Group, October 1993.) Geneva : World Health Organization, 1994:4344.
  • 9
    Cossar JH, Reid D. Health hazards of international travel. World Health Stat Q 1989;42:6169.
  • 10
    Steffen R. Travel medicine - prevention based on epidemiological data. Trans R Soc Trop Med Hyg 1991;85:156162.
  • 11
    Koziol DE, Henderson DK. Risk analysis and occupational exposure to HIV and HBV Curr Opin Infect Dis 1993;6:506510.
  • 12
    Bell DM, Shapiro CN, Culver DH, et al. Risk of hepatitis B and human immunodeficiency virus transmission to a patient from an infected surgeon due to percutaneous injury during an invasive procedure: estimates based on a model. Infect Agents Dis 1992;1:263269.
  • 13
    Hawkes S, Hart GJ, Johnson AM, et al. Risk behaviour and HIV prevalence in international travelers. AIDS 1994;8:247252.
  • 14
    Stricker M, Steffen R, Hornung R, et al. Flüchtige sexuelle Kontakte von Schweizer Touristen in den Tropen. Munch Med Wschr 1990;132:175177.
  • 15
    André FE. Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccine. Vaccine 1990;8(Suppl):7478.
  • 16
    Wahl M, Hermodsson S, Iwarson S. Hepatitis B vaccination with short dose intervals - a possible alternative for post-exposure prophylaxis Infection 1988;16:229232.
  • 17
    Harries AD, Clark M, Beeching NJ, et al. Early anti-HBs antibody response to accelerated and to conventional hepatitis B vaccination regimens in healthy persons. J Infect 1991;23:251254.
  • 18
    Marchou B, Picot N, Chavanet P, et al. Three-week hepatitis B vaccination provides protective immunity. Vaccine 1993;11:13831385.
  • 19
    Van Damme P, Cramm M, Van Gompel A, et al. Analysis of travelers profile in Belgium. Proceedings of the Third Conference on International Travel Medicine, Paris, France, April 2629, 1993:267.
  • 20
    Hollinger FB, Adam E, Heiberg D, Melnick JL. Response to hepatitis B vaccine in a young adult population. Chapter 29. In: SzmunessW, AlterHJ, MaynardJE, eds. Viral Hepatitis: 1981 International Symposium. Philadelphia : The Franklin Institute Press, 1982: 421466.
  • 21
    Bernard KW, Roberts MA, Sumner J, et al. Human diploid cell rabies vaccine: effectiveness of immunization with small intradermal or subcutaneous doses. JAMA 1982; 247:11381142.
  • 22
    Nicholson KG, Farrow PR, Bijok U, Barth R. Pre-exposure studies with purified chick embryo cell culture rabies vaccine and human diploid cell vaccine: serological and clinical responses in man. Vaccine 1987; 5:208210.
  • 23
    Bock HL, Klockmann U, Jüngst C, et al. A new vaccine against tick-borne encephalitis: initial trial in man including a dose-response study. Vaccine 1990;8:2224.
  • 24
    Harabacz I, Bock HL, Jüngst C, et al. A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens. Vaccine 1992; 10:145150.
  • 25
    Centers for Disease Control. Health Information for International Travel 1991. Washington , DC : U.S. Government Printing Office, 1991: 82116.
  • 26
    Hess G, Hingst V, Cseke J, et al. Influence of vaccination schedules and host factors on antibody response following hepatitis B vaccination. Eur J Clin Microbiol Infect Dis 1992; 11:334340.
  • 27
    Jilg W, Schmidt M, Deinhardt F, Vaccination against hepatitis B: comparison of three different vaccination schedules. J Infect Dis 1989; 160:766769.
  • 28
    Iwarson S. Post-exposure prophylaxis for hepatitis B: active or passive Lancet 1989; (ii):146147.